QualityStocks News Alert
  The QualityStocks Daily Newsletter for Monday April 6th, 2009 Blog  |  Video  |  Market Basics  |  Quotes & News  |  Clients  |  Partners  |  About Us  |  Contact Us

Today's Top 3 Investment Newsletters

1.

Small Cap Voice (BJCT)

2.

The Penny Play (UTRM)

3.

Wall Street Resources (GSAC)


The QualityStocks Daily

Modavox Inc. (MDVX)

Today we are highlighting Modavox Inc. (MDVX), here at the QualityStocks Daily Newsletter.

Modavox, Inc. is a customized communications company who produces and syndicates online audio and video. They develop software products that enhance and protect global network based communications. Founded in 1999, Modavox delivers content through their patented technology, direct to desktops and Internet-enabled devices. Modavox provides managed access for live and on-demand Internet radio broadcasting, E learning, and rich media advertising. The Company has their headquarters in Phoenix , Arizona .

The Company has two operational divisions: Modavox Network, and Modavox Interactive Agency. Their Modavox Network Internet Radio/TV Division includes The VoiceAmerica™ Networks and World Talk Radio™, leaders in Internet talk radio, and BoomBox Radio™ their patented Internet radio software product line. This division also has BoomBox Video®. In addition, this division includes corporate and custom branded radio solutions, and production, broadcasting, and complete host services. This division engages in ecommerce, sponsorship, and advertising partnerships, and provides global content delivery and comprehensive reporting.

Modavox's Interactive Solutions Division has their Modavox Enterprise™ Platform, which engages in enterprise communications. This division also has their advertising product Stream Syndicate™ Online Audio and Video Advertising. They also provide global content delivery and comprehensive reporting.

Modavox announced in 2008 that they have an agreement with OasisTV (www.oasistv.com) to broadcast exclusively their online library. The network's content will receive distribution via the Modavox's BoomBox™ Video Platform and will use their StreamSyndicate™ Advertising Platform.

Last month, Modavox, Inc. announced their newly enhanced broadcast platform through their new websites for both of their Live Internet Talk Radio networks, VoiceAmerica and World Talk Radio. The new sites will have new features including multiple weblinks so that show hosts can maximize traffic to their business and social networking sites. They will also have more featured shows and guests. In addition, they will have larger featured show and sponsor banners, as well as optional video capability for all talk show hosts on the network.

Modavox Inc. (MDVX) closed Monday's session at $3.10 up $0.45 or 16.98 percent. Volume was 303,216 for a 3-month average volume of 54,563.50.

AmMex Gold Mining Corp. (AMXG)

Today we are highlighting AmMex Gold Mining Corp. (AMXG), here at the QualityStocks Daily Newsletter.

AmMex Gold Mining Corp. is a precious metals exploration company that trades on the OTCBB. Their corporate mission is to build shareholder value by acquiring a diversified portfolio of advanced-stage precious metals assets in proven, resource-rich areas around the world. However, the Company will have a focus on properties in politically safe areas of the world. Their emphasis will be in North and South America where the Company has a strong presence and expertise. The Company has a subsidiary office in Durango , Mexico .

AmMex Gold Mining Corp.'s portfolio will consist of three distinct types of mining properties. One is promising exploration targets. The second is highly leveraged, out-of-the-money precious metal deposits. The third is former producing properties with significant untapped exploration potential.

The Company's Cold Creek Gold Project is in Cassia County , Idaho . It is approximately 15 miles south of Oakley near the northern Utah-Nevada border. This project is an intermediate-stage, epithermal hot spring-type precious metals exploration target. It consists of an 85,000-ounce open-ended gold resource. Meridian Minerals originally discovered gold mineralization at Cold Creek in the summer of 1985.

The Company also has their Cerro Gordo Target, in the Concha Concession in Mexico . AmMex approached EXMIN (EXM.V), in 2007, to stake an area with known potential for polymetallic mineralization near Melchor Ocampo. EXMIN has a larger infrastructure in Mexico . They were available and able to move quickly to acquire this ground declared open for staking by the Mexican government.

Under the agreement, EXMIN staked the concession based on geologic information provided by AmMex Gold Mining Corp. This was for a 30 percent interest. AmMex provides detailed data and funds a first round of exploration drilling totaling US$150,000. This is for their 70 percent interest there. Title was received in February 2008 for this project. EXMIN is the project operator for the initial phase of exploration.

Today, AmMex Gold Mining Corp. (AMXG) closed trading at $0.03 up $0.01 or 87.50 percent. Volume was 19,310 for a 3-month average volume of 9,453.97.

Angiotech Pharmaceuticals Inc. (ANPI)

Today, we choose to highlight Angiotech Pharmaceuticals Inc. (ANPI), here at the QualityStocks Daily Newsletter.

Headquartered in Vancouver , British Columbia , Canada , Angiotech is a global specialty pharmaceutical and medical device company. They list on the TSX under ANP and on the NASDAQ under ANPI. The Company discovers, develops, and markets innovative technologies and medical products mainly for local diseases or for complications associated with medical device implants, surgical interventions, and acute injury.

Angiotech Pharmaceuticals uses their drug screening capabilities to identify new uses for known pharmaceutical compounds. They look for compounds that address the underlying biological causes of conditions that can occur concurrently with medical device implantation, surgery, or acute trauma. The Company works to identify appropriate drugs. They then proceed to formulate the drug, or combination of drugs, with their family of biomaterials and drug delivery technologies. This is to develop a novel drug-eluting medical device or surgical implant.

Angiotech Pharmaceuticals' initial lead product is the TAXUS® drug-eluting coronary stent. It was co-developed and is now sold by Boston Scientific Corporation. The TAXUS® drug-eluting coronary stent is implanted in more than four million patients worldwide. The Company's portfolio of intellectual property developed, licensed, or acquired includes over 250 issued U.S. patents and 230 pending U.S. patent applications.

Angiotech also has their Bio-Seal™ Lung Biopsy Tract Plug System. Bio-Seal is a novel technology designed to reduce the incidence of post-operative pneumothorax (collapsed lung). This is in patients who undergo lung biopsy procedures. The Bio-Seal technology involves the placement of an expanding hydrogel plug along the biopsy needle track during the procedure. This closes off the track to the subsequent influx of air into the chest during respiration after the biopsy needle is withdrawn. The seal is airtight and the plug is absorbed into the body after healing of the puncture site.

On March 9, 2009, Angiotech Pharmaceuticals, Inc. announced positive clinical study results for their Bio-Seal™ Lung Biopsy Tract Plug System. This was at the Society of Interventional Radiologists Annual Scientifi Meeting in San Diego , California . The trial assessed the safety and efficacy of Bio-Seal in patients undergoing lung biopsy procedures and demonstrated a statistically significant clinical benefit in the group receiving BioSeal.

Dr. William Hunter, President and CEO of Angiotech, said, "We are extremely pleased that the Bio-Seal treatment arm hit the primary end point of clinical success. These results indicate that Bio-Seal improves the existing technology used to diagnose lung cancer by significantly reducing the rates of pneumothorax."

Last Tuesday, Angiotech announced they completed an Amended and Restated Distribution and License Agreement with their partner Baxter International Inc. (Baxter). Angiotech will receive $25 million as consideration for the Amended and Restated Distribution and License Agreement.

Angiotech Pharmaceuticals Inc. (ANPI) closed Monday's trading session at $0.49 down $0.01 or 2.00 percent. Volume was 76,765 for a 3-month average volume of 227,130.

Bioject Medical Technologies Inc. (BJCT)

Today, SmallCap Voice reported on Bioject Medical Technologies Inc. (BJCT), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Trading on the OTCBB, Bioject Medical Technologies Inc., is a developer and manufacturer of needle-free injection therapy systems. These systems work by forcing medication at high speed through a tiny orifice held against the skin. This creates a fine stream of high-pressure fluid penetrating the skin and depositing medication in the tissue beneath. Bioject Medical Technologies focuses their efforts on developing mutually beneficial agreements with leading pharmaceutical, biotechnology, and veterinary companies. Founded in 1985, the Company has their corporate headquarters in Portland , Oregon .

The Company's systems deliver medication in a fraction of a second. They design their systems to deliver injected medications comfortably, accurately, and quickly. Bioject has developed a broad technology platform for delivering many different types of medications and vaccines to the subcutaneous and intramuscular depths. They are currently developing systems and are in clinical trials for intradermal injections.

Bioject Medical Technologies Inc. has developed a portfolio of injection systems based on their core technology. These include durable devices designed for heavy use in a professional healthcare environment, and small, lightweight injectors designed for home use. They are also developing inexpensive, pre-filled, disposable injection systems with partners.

Today, Bioject Medical Technologies Inc. announced that the U.S. Food and Drug Administration (FDA) granted market clearance for the Zetajet™ Needle-Free Injection Therapy System. Bioject's new Zetajet™ Needle-free Injection Therapy System is a compact, spring-powered, needle-free injection device. Its intent is to deliver vaccines and injectable medications either subcutaneously or intramuscularly. The Zetajet™ uses jet force to propel a finely dispersed stream of injectable medication into the subcutaneous or intramuscular tissue without the use of a needle. The syringe assembly has a unique "auto-disable" feature that prevents re-use of the syringe.

Today, Bioject Medical Technologies Inc. (BJCT) closed at $0.21 up $0.13 or 162.50 percent. Volume was 96,131 significantly higher than their 3-month average volume of 8,439.68.

Bruker Corporation (BRKR)

Greenbackers reported on Bruker Corporation (BRKR), and we are as well, here at the QualityStocks Daily Newsletter.

Headquartered in Billerica , Massachusetts , Bruker Corporation is a leading provider of high-performance scientific instruments and solutions. These are for molecular and materials research, as well as for industrial and applied analysis. They are the parent company of Bruker AXS, Bruker BioSpin, Bruker Daltonics, Bruker Optics, and Bruker Advanced Supercon. Founded in 1991, the Company trades on NASDAQ.

Their Bruker AXS is a leading global developer and manufacturer of analytical X-ray systems, optical emission spectrometers, and combustion analyzers for elemental analysis, materials research, and crystallographic investigations. This subsidiary's solutions enable a wide range of customers in research and industry to make technological advancements and to accelerate their progress. These industries include chemistry, petrochemistry, pharmacy, metals and steel, semiconductor, cement, minerals and mining, automotive, forensics, environmental, art and conservation, nanotechnology, and life sciences.

The Bruker BioSpin subsidiary is a market and technology leader in analytical magnetic resonance instruments including Nuclear Magnetic Resonance (NMR), preclinical MRI, and EPR. They deliver a broad range of magnetic resonance research tools enabling life science, materials science, analytical chemistry, process control, and clinical research. Bruker BioSpin is also the leading manufacturer of superconducting high and ultra high field magnets for NMR and MRI.

Bruker Daltonics is a leading manufacturer of mass spectrometry (MS) instruments and accessories for life science, pharmaceutical, biochemical, and chemical research, as well as for forensics and food safety. They are also a global leader in nuclear, biological, and chemical detection. Their CBRNE product line has its basis in technologies including mass spectrometry and ion mobility spectrometry.

Bruker Optics offers advanced Fouier transform (FT-) Infrared and Near Infrared, Raman, time domain low resolution NMR, and terahertz spectrometers for academic and industrial research, process, and quality control. 

Bruker Advanced Supercon is a leader in the development and industrial production of low-temperature superconducting (LTS) wires used primarily in Magnetic Resonance Imaging (MRI), Nuclear Magnetic Resonance (NMR), Fourier Transform Mass Spectrometry (FTMS), High-Energy Physics (HEP), and nuclear-fusion research magnet applications. They also develop and manufacture high-temperature superconductors (HTS) and HTS devices. They base these devices on their two complementary, advanced HTS technology platforms for BSSCO and YBCO conductors.

Last Friday, Bruker Advanced Supercon, Inc. announced that they closed the acquisition of the research instruments portion of Varian Medical Systems' ACCEL Instruments GmbH subsidiary in Bergisch-Gladbach , Germany . Varian acquired ACCEL, including both their businesses in research instruments (RI) and proton therapy, in January 2007. Varian is retaining the proton therapy business, which will now operate as Varian Particle Therapy, while Bruker has acquired substantially all of the assets of the RI business. The asset deal, which was signed by Bruker and Varian in February 2009, closed on April 1, 2009.

Dr. Burkhard Prause, Chief Executive Officer of Bruker Advanced Supercon, Inc., explained: "This acquisition opens an important new chapter in the history of our Bruker Advanced Supercon business. It positions us for rapid revenue and margin growth in several exciting markets, including renewable energy research, the more stable and energy efficient electricity grids of the future, next-generation materials research and manufacturing, as well as components for cutting-edge medical devices."

Bruker Corporation (BRKR) closed today's session at $6.07 down $0.21 or 3.34 percent. Volume was 673,507 for a 3-month average volume of 763,648.

Orsus Xelent Technologies Inc. (ORS)

Today we are highlighting Orsus Xelent Technologies Inc. (ORS), here at the QualityStocks Daily Newsletter.

Headquartered in Beijing , China , Orsus Xelent Technologies, Inc. is an emerging designer and manufacturer of award-winning mobile phones for the Asian market. This is mainly in the People's Republic of China (PRC). Launched in 2004, the Company's business encompasses the design of mobile phones, related digital circuits, and software development. The Company trades on the NYSE Alternext U.S. , formerly known as the American Stock Exchange (AMEX).

Orsus Xelent Technologies Inc. is a recognized pioneer in mobile phone integration technology. They introduced the region's first wristwatch-style cellular phone. They continue to work to manufacture and market state-of-the-art phones. These include phones with advanced features such as finger print recognition and touch-screen displays. The Company also focuses on developing and marketing special application mobile phones for specialized users in a broad spectrum of professions in business and government. This is through their Proxlink trademark. The Company's mobile phones include GSM/GPRS, PDA, and CDMA, under their two known brand names, Orsus and the aforementioned Proxlink.

Orsus Xelent Technologies' business comprises the design and manufacture of mobile phones and digital circuits, as well as the software development, R&D, and design of mobile phone integration technology. Their business also involves mobile phone quality control and project management. They have more than 179 service call centers across the People's Republic of China . They also have additional offices in New York , Shanghai , Hong Kong, Shenzhen, and Tianjin .

Last Thursday, Orsus Xelent Technologies, Inc. announced that their Board of Directors appointed Mr. Guoji Liu to serve as CEO and director of the Company effective immediately. Mr. Guoji Liu is a 15-year veteran of the cell phone industry. He has been a Deputy General Manager of the Company since 2007. His previous positions include Supervisor of the Pantech Beijing office and Sales Director for Xiamen Chabridge Telecom Equipment Co. Ltd. He was also General Manager of the marketing department at Tianjin Sanyo Telecommunication Corp., among other positions he has held in his career.

Orsus Xelent Technologies Inc. (ORS) closed Monday's session at $0.70 up $0.28 or 66.67 percent. Volume was 2,299,251 for a 3-month average volume of 120,116.

Vasomedical Inc. (VASO)

Today we are highlighting Vasomedical Inc. (VASO), here at the QualityStocks Daily Newsletter.

Vasomedical, Inc. is a leader in EECP® (enhanced external counterpulsation) devices and services for the non-invasive treatment and management of cardiovascular diseases. EECP therapy serves to increase circulation in areas of the heart with less than adequate blood supply. This therapy also serves to improve systemic vascular function, including improved endothelial cell function. Vasomedical Inc. trades on the OTCBB as part of the Medical Appliances & Equipment industry in the Healthcare sector. The Company's headquarters are in Westbury , New York .

Vasomedical is expanding into the non-invasive diagnostic field by introducing new products such as the Holter monitors. Holter devices monitor and record a patient's cardiac rhythm. Data generated from the Holter monitor undergoes analysis and then finds use in the early detection of cardiac abnormalities such as ischemia.

The Company's core technology, the aforementioned EECP® therapy, provides healthcare professionals that non-invasive therapy for patients suffering from cardiovascular diseases. Vasomedical has a leadership position with the Lumenair™ EECP Therapy System, with over 1,000 systems installed globally. The Company's growth strategy is their long-term goal of achieving broad-based clinical acceptance of EECP therapy.

Today, Vasomedical, Inc. announced that they received FDA 510k clearance to market Vasomedical-BIOX 1305 ECG Holter Monitor and CB Series Ambulatory ECG Analysis Software. The Vasomedical-BIOX 1305 Holter Monitor is the latest addition to their product line. The Model 1305 is a compact, lightweight, 3-channel ECG Holter monitor designed for monitoring a patient's cardiac rhythm for 24 to 72 hours and recording ECG on a standard SD memory card. This product features a high signal sampling rate and high-resolution digital recording for comprehensive data analysis. This monitor has already received CE Marking certification to market in the European Union countries.

Data recorded by the Model 1305 can be quickly analyzed using the proprietary Vasomedical-BIOX CB Series Analysis Software. The CB series software provides clear, quick, and accurate recognition of QRS complexes and classification. The CB series software also provides a proprietary two-tier automatic classification process for "suspicious" waveforms, as well as comprehensive event reports and ST-segment reports. In addition, the software has many other data viewing, analysis, and reporting capabilities.

Vasomedical Inc. (VASO) closed at $0.04 up $0.02 or 73.91 percent. Volume was 283,107 for a 3-month average volume of 46,217.50.

ZBB Energy Corporation (ZBB)

Today, we choose to highlight ZBB Energy Corporation (ZBB), here at the QualityStocks Daily Newsletter.

ZBB Energy Corporation provides clean energy storage solutions based on proprietary zinc rechargeable energy storage technology. Headquartered in Menomonee Falls , Wisconsin , with additional offices located in Perth , Australia , they trade on the NYSE Alternex, formerly the American Stock Exchange (AMEX), as part of the Electric Utilities industry. Founded in 1998, their clean energy storage solutions address requirements in markets such as alternative energy applications, large electrical utilities, and green residential and commercial architecture.

ZBB Energy Corporation markets their modular, transportable, and environmentally friendly Zinc Energy Storage Systems (ZESS). The Company and their subsidiaries develop and manufacture these energy storage systems for utility companies, renewable energy generators, commercial, and industrial customers. The basis of their solutions is their proprietary zinc-bromine rechargeable electrical energy storage technology. Their systems combine their zinc-bromine batteries with computer hardware and software that interface with clients' power sources to recharge during off peak times and discharge power as required.

ZBB's systems are for use in load management for generation, transmission, and distribution utilities and energy service companies. They are also for commercial and industrial customers. In addition, their systems are for the storage of renewable energy, such as wind, hydro, and solar energy production. These systems also find use for the uninterruptible power supply and power quality protection from voltage, current, or frequency deviations for both commercial and industrial customers.

Last month, ZBB Energy Corporation announced that they received an order for a standard, modular, ZESS 50 energy storage system incorporating the Company's new and proprietary ZESS POWR™ power electronics system, from Likusasa Engineering and Contracting Pty Ltd. (Likusasa) of South Africa . Likusasa provides a full range of specialist project-management skills. Likusasa participates in the telecommunications and power infrastructure sectors throughout the sub-Sahara and lower regions of continental Africa .

ZBB Energy Corporation (ZBB) closed today at $0.90 up $0.05 or 5.88 percent. Volume was 6,500 for a 3-month average volume of 16,050.80.

The QualityStocks Company Corner

Axial Vector Energy Corp (AXVC)
Kraig Biocraft Labs (KBLB)

GreenChek Technology (GCHK)
GTX Corp (GTXO)

Axial Vector Energy Corporation (AXVC)

The QualityStocks Daily Newsletter would like to spotlight Axial Vector Energy Corp. (AXVC). Today, Axial Vector Energy Corp. closed trading at $0.4250, which was down $0.0550 or 11.46 percent. Their volume today was 151,336 shares. Their 3-month average volume is 203,406.

Axial Vector Energy Corporation (AXVC) announced today that they have entered negotiations to acquire Adaptive Propulsion Systems LLC. The company anticipates closing the acquisition and transferring the technology in the next few days.

Axial Vector Energy Corporation (AXVC) a publicly traded, development-stage company providing global energy solutions, develops multi-fuel engines and generators for use primarily in military and commercial applications.

Founded in 2002, with headquarters in Portland, Oregon, Axial Vector - through a joint venture agreement with Adaptive Propulsion Systems, LLC - develops and manufactures their engines and generators with an eye toward environmental responsibility and social benefit.

Axial Vector Energy Corporation owns, develops and licenses a technologically advanced suite of internal combustion engines and electric power generation modules. The company has also developed the world's only “coreless” no iron electric motors, which consume one half the electricity of conventional electric motors.

These cutting-edge technologies are focused on fulfilling global engine and energy needs by delivering greater fuel-efficiency, cost effectiveness, versatility, and environmental sensitivity than ever before in venues from the commercial to the industrial, including the vehicular and military sectors. Disclaimer

Axial Vector Energy Corporation Blog

Axial Vector Energy Corporation News:

Axial Vector Negotiates to Acquire Adaptive Propulsion Systems

AVEC Announces Today the Appointment of Miguel A. Gonzales as the Director of the Company and Head of the Audit Committee

Adaptive Propulsion Systems and Axial Vector Energy Schedule Technology Transfer Closing Date for April 4Th, 2009 Due to Successful Demonstrations Last Week

Kraig Biocraft Laboratories, Inc. (KBLB)

The QualityStocks Daily Newsletter would like to spotlight Kraig Biocraft Laboratories, Inc. (KBLB) Today, Kraig Biocraft Laboratories, Inc. closed trading at $0.29, for no change. Their volume today was 22,377 for a 3-month average volume of 17,855.60 shares.

Kraig Biocraft Laboratories, Inc. today confirmed that they have instructed their attorneys to confer with the market oversight authority FINRA in order to obtain clearance to announce the record date for their stock dividend.

Kraig Biocraft Laboratories, Inc. a biotechnology company, has their focus on developing high performance polymers and technical fibers. The company is utilizing their proprietary genetic engineering technology to develop and produce polymers and protein-based materials, including Spider silk, which may have numerous commercial and consumer applications.

Kraig Biocraft Laboratories, Inc. is working with university scientists and laboratories to create these new polymers that have potentially broad applications in the multi-billion dollar marketplace for high performance polymers. The company sponsors and collaborates on research projects within university genetic engineering laboratories as a means of utilizing the greatest minds in their field.

Spider Silk is one of the strongest fibers produced in nature. The spider's repelling silk is of particular commercial interest since it is both extremely strong and extremely flexible. Although exciting commercial opportunities exist for the natural polymer, there is no known way to produce the fibers in commercial quantity. KraigLabs, in cooperation with two leading universities, has acquired proprietary genetic engineering technology to unlock the mystery.

CEO Kim Thompson leads the company with formal education in the fields of economics and law. With interest in genetic engineering dating back to the 1970s, Mr. Thompson has invented a pending provisional patent application for a number of organic polymers. This patent application has been assigned to benefit Kraig Biocraft and is a central part of the company's efforts in bringing those inventions to the market. Disclaimer

Kraig Biocraft Laboratories, Inc. Blog

News for Kraig Biocraft Laboratories Inc.

Kraig Biocraft Laboratories, Inc. Stock Dividend Update

Kraig Biocraft Laboratories, Inc. Succeeds in Attaining Higher Levels of Transient Expression of Targeted DNA

FiSpace.net Announces Commentary for Investors Dividend-Related Companies KBLB, CGFI, AMNE, UCBI, SYNJ, TIBB, EVGG

GreenChek Technology Inc. (GCHK)

The QualityStocks Daily Newsletter would like to spotlight GreenChek Technology Inc. (GCHK) Today GreenChek Technology Inc. closed trading at $0.24, which was up $0.04 or 20.00 percent. Their volume today was 22,317 shares. Their 3-month average volume is 113,894 shares.

GreenChek Technology Inc. provides world-class mobile Greenhouse Gas Emissions Reduction technology, while greatly enhancing fuel economy for the mobile transportation industry. The company's mission is to become the pre-eminent supplier of Onboard Hydrogen Generation and Injection (OHGI) technology for mobile transportation and industrial power generation applications.

GreenChek Technology Inc.'s patent-pending OHGI technology efficiently separates distilled water (H2O) into its two base elements, hydrogen and oxygen, two of the most abundant elements on the planet. By injecting the elements into a traditional combustion engine, OHGI technology significantly decreases emissions and reduces fuel consumption. The only by-product is safe, clean, water vapor with reduced greenhouse gases.

GreenChek Technology Inc. has designed its revolutionary Onboard Hydrogen Generation and Injection (OHGI) technology to take a leading position in the emerging market for emissions reduction technology and fuel economy enhancement. Through this technology, the company offers a clean, safe, inexpensive, alternative energy solution for the mobile transportation and industrial power generative industries as well as for individual consumers.

GreenChek Technology Inc. intends to leverage its proven in-house expertise in OHGI technology to achieve long-term growth, while emerging as a global leader in the development and production of emission reducing devices for mobile and power generative applications. The scalability and versatility of the company's OHGI technology allows easy adaptability, enabling aggressively penetration and the opportunity to establish market share in numerous industries. Disclaimer

GreenChek Technology Inc. Daily Blog

GreenChek Technology Inc. News:

Daily Small Cap Market News and Stock Highlights from SmallCapVoice.com (GCHK, RNNM)

FiSpace.net Announces Commentary for Investors of Alternative Fuel Companies GCHK, SSTP, CBEH, CLNE, BP, HES

GreenChek Announces Advancement in ERD Technology

GTX Corp (GTXO)

The QualityStocks Daily Newsletter would like to spotlight GTX Corp (GTXO). Today GTX Corp closed trading at $0.06, for no change. Their volume today was 60,498 shares. Their 3-month average volume is 369,295 shares.

CodeAmber News Service expands its reach with the addition of new affiliates, Business Talk Radio Network and Lifestyle Talk Radio Network. In the first one hundred days under the new leadership of GTX Corp. CodeAmber News Service increased every quantifiable metric by double digits; reach and viewership are up.

GTX Corp is focused on developing miniaturized GPS tracking and cellular location-transmitting technology platforms for integration into a wide variety of branded licensee consumer products. The company's patented Personal Location Services (PLS) platforms feature miniaturized, always-on Assisted-GPS tracking and wireless location-reporting technologies that provide continuous real-time coordinates.

Since inception, the company has been dedicated to creating patented GPS/GPRS/GSM technologies and establishing key relationships with licensed, branded partners to bring real-time tracking solutions to an assortment of consumer products. GTX Corp plans to integrate its gpVector™ units in a host of lifestyle products and applications used to track children, those afflicted with Alzheimer's, outdoor adventurers, military personnel, police, fire, and public safety workers, and nearly any highly valued asset.

According to Frost & Sullivan, the market for personal location services is expected to grow to an $8 billion dollar industry by 2011. GTX Corp has established a pioneering position within the industry by spending more than$3 million in research and development over the past six years, and is poised to grow rapidly as the global demand for GPS devices continues its explosive growth.

The company is led by CEO, Founder and Chairman Mr. Patrick Bertagna who has more than 25 years experience building companies. He began his career importing apparel from Europe and later went on to design and manufacture a full line of clothing, accessories and footwear in over 20 countries, with sales exceeding $27 million. He later began transitioning into the world of software technology and founded Barcode World, Inc., an international supply chain management application company that grew to 450 premier branded accounts. Disclaimer

GTX Corp Corporation Blog

GTX Corp News:

CodeAmber News Service (CANS) Expands Syndication of Vital Missing Persons' Alert Network

We Know Where You Are

Validation of 2-Way GPS Marketplace Shifts Demand From Technology to Customizable Applications

 

Daily Video
Get the latest market news every weekday at 11am EST with QualityStocks.net anchors Cathy Rankin, Vanessa Ramirez and Jenn Hoffman.
Video.QualityStocks.net


Sponsors of the Day

 

The QualityStocks Public Company Sponsor News

 

QualityStocks By The Numbers Report

 

 

 

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

Home | Blog | Video | Market Basics | Media | Partners | Clients | About Us | Contact Us | Disclaimer | Unsubscribe
Copyright 2006-2009 QualityStocks 3370 N. Hayden Rd. Suite 123-591 Scottsdale, AZ 85251 480-308-0703